Oncotarget
Durvalumab and Tremelimumab Before Surgery in Patients With HR+/HER2-negative Breast Cancer
March 27, 2024
BUFFALO, NY- March 27, 2024 A new #research pap
Oncotarget is a primarily oncology-focused, peer-…
Visit Podcast Website
RSS Podcast Feed
Subscribe
Share
Add to MyCast